![]() WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. | ![]() Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. | ![]() Prevail Therapeutics Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease. | |
Founding Date | Founding Date 2000 | Founding Date 2004 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations New York, US HQ |
Employees | Employees 39,414 | Employees 158 | Employees 489% increase |
Valuation ($) | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 787.7 m |
Financial | |||
Revenue (est.) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥23.8b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥21.3b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ¥19.3b (FY, 2025) | Net income (CHF61.7m) (FY, 2025) | Net income ($63.2m) (FY, 2019) |
Funding | |||
Total funding raised | Total funding raised $ 902.6m | Total funding raised N/A | Total funding raised $ 125m |

Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
View company
Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
View company